BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

842 related articles for article (PubMed ID: 19515798)

  • 21. Human tonsil implants xenotransplanted in SCID mice display broad lymphocytic diversity and cellular activation profile similar to those in the original lymphoid organ.
    Vallet V; Mauray S; Kindler V; Aubry D; Ruegg M; Cherpillod J; Waridel F; Schapira M; Duchosal MA
    Xenotransplantation; 2005 Jan; 12(1):38-48. PubMed ID: 15598272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional CD5+ B cells develop predominantly in the spleen of NOD/SCID/gammac(null) (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD34+ cells.
    Matsumura T; Kametani Y; Ando K; Hirano Y; Katano I; Ito R; Shiina M; Tsukamoto H; Saito Y; Tokuda Y; Kato S; Ito M; Motoyoshi K; Habu S
    Exp Hematol; 2003 Sep; 31(9):789-97. PubMed ID: 12962725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-transplantation of human fetal thymus, bone and CD34(+) cells into young adult immunodeficient NOD/SCID IL2Rγ(null) mice optimizes humanized mice that mount adaptive antibody responses.
    Chung YS; Son JK; Choi B; Joo SY; Lee YS; Park JB; Moon H; Kim TJ; Kim SH; Hong S; Chang J; Kang MS; Kim SJ
    Clin Immunol; 2015 Apr; 157(2):156-65. PubMed ID: 25725428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human T cells in the SCID-hu mouse are phenotypically normal and functionally competent.
    Krowka JF; Sarin S; Namikawa R; McCune JM; Kaneshima H
    J Immunol; 1991 Jun; 146(11):3751-6. PubMed ID: 1827814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reconstitution of human lymphocytes following ex vivo expansion of human umbilical cord blood CD34+ cells and transplantation in Rag2-/- gamma c-/- mice model.
    Choi BK; Joo SY; Moon C; Park KS; Kim SH; Park JB; Jung GO; Choi GS; Kwon CH; Chun JM; Joh JW; Lee SK; Kim SJ
    Transplant Proc; 2008 Oct; 40(8):2655-60. PubMed ID: 18929829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
    Majlessi L; Bordenave G
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compartmentalization of allogeneic T-cell responses in the bone marrow and spleen of humanized NOD/SCID mice containing activated human resident myeloid dendritic cells.
    Vuckovic S; Abdul Wahid FS; Rice A; Kato M; Khalil D; Rodwell R; Hart DN
    Exp Hematol; 2008 Nov; 36(11):1496-506. PubMed ID: 18715688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3.
    Kindler V; Zubler RH
    J Immunol; 1997 Sep; 159(5):2085-90. PubMed ID: 9278293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice.
    Lepus CM; Gibson TF; Gerber SA; Kawikova I; Szczepanik M; Hossain J; Ablamunits V; Kirkiles-Smith N; Herold KC; Donis RO; Bothwell AL; Pober JS; Harding MJ
    Hum Immunol; 2009 Oct; 70(10):790-802. PubMed ID: 19524633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivo.
    Ito A; Ishida T; Utsunomiya A; Sato F; Mori F; Yano H; Inagaki A; Suzuki S; Takino H; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
    J Immunol; 2009 Oct; 183(7):4782-91. PubMed ID: 19748990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model.
    Ito A; Ishida T; Yano H; Inagaki A; Suzuki S; Sato F; Takino H; Mori F; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
    Cancer Immunol Immunother; 2009 Aug; 58(8):1195-206. PubMed ID: 19048251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis factor promotes human T-cell development in nonobese diabetic/severe combined immunodeficient mice.
    Samira S; Ferrand C; Peled A; Nagler A; Tovbin Y; Ben-Hur H; Taylor N; Globerson A; Lapidot T
    Stem Cells; 2004; 22(6):1085-100. PubMed ID: 15536198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiation.
    Otto M; Chen X; Martin WJ; Leung W; Knowles J; Holladay M; Houston J; Handgretinger R; Barfield RC
    Stem Cells; 2007 Feb; 25(2):537-42. PubMed ID: 17023516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells.
    Bohlen H; Manzke O; Titzer S; Lorenzen J; Kube D; Engert A; Abken H; Wolf J; Diehl V; Tesch H
    Cancer Res; 1997 May; 57(9):1704-9. PubMed ID: 9135012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency.
    Murphy WJ; Conlon KC; Sayers TJ; Wiltrout RH; Back TC; Ortaldo JR; Longo DL
    J Immunol; 1993 Apr; 150(8 Pt 1):3634-42. PubMed ID: 8468492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell-mediated control of Epstein-Barr virus infection in humanized mice.
    Yajima M; Imadome K; Nakagawa A; Watanabe S; Terashima K; Nakamura H; Ito M; Shimizu N; Yamamoto N; Fujiwara S
    J Infect Dis; 2009 Nov; 200(10):1611-5. PubMed ID: 19832115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human T-and B-cell functions in SCID-hu mice.
    Roncarolo MG; Carballido JM; Rouleau M; Namikawa R; de Vries JE
    Semin Immunol; 1996 Aug; 8(4):207-13. PubMed ID: 8883143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engraftment of human T, B and NK cells in CB.17 SCID/beige mice by transfer of human spleen cells.
    Yacoub-Youssef H; Marcheix B; Calise D; Thiers JC; Therville N; Benoist H; Blaes N; Ségui B; Dambrin C; Thomsen M
    Transpl Immunol; 2005 Dec; 15(2):157-64. PubMed ID: 16412960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human T cell development in the liver of humanized NOD/SCID/IL-2Rγ(null)(NSG) mice generated by intrahepatic injection of CD34(+) human (h) cord blood (CB) cells.
    Choi B; Chun E; Kim M; Kim SY; Kim ST; Yoon K; Lee KY; Kim SJ
    Clin Immunol; 2011 Jun; 139(3):321-35. PubMed ID: 21429805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-27 induces the production of IgG1 by human B cells.
    Boumendjel A; Tawk L; Malefijt Rde W; Boulay V; Yssel H; Pène J
    Eur Cytokine Netw; 2006 Dec; 17(4):281-9. PubMed ID: 17353163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.